Geneva, Switzerland - Unilabs, a
leading medical diagnostic services company, today announces that
Jos Lamers has been appointed CEO succeeding Jean-Paul Rigaudeau,
effective October 7, 2013.
Jos Lamers joins Unilabs as CEO, from his previous position as
CEO of Nucletron, a radiotherapy company and global leader in
brachytherapy that was acquired by Elekta in 2011. Prior to his CEO
role at Nucletron, Jos was a Regional President and member of the
Executive Management Board at Eurofins Scientific. He succeeds
Jean-Paul Rigaudeau, who will be leaving after over four years of
successfully leading the Company.
"The Company is pleased that Jos Lamers will join as CEO and we
warmly welcome him to Unilabs. Jos has a proven track record of
leading multi-national healthcare organizations, and his valuable
experience makes him the ideal leader to build upon the Company's
strong foundation and take Unilabs to its next stage of
development," said Paul Hökfelt, Chairman of the Board of
Unilabs
"Unilabs is a leader in diagnostics throughout Europe, and I am
delighted to work with such a dynamic and growing company," said
Jos Lamers.
"On behalf of the Board and the shareholders I would also like
to thank Jean-Paul for his significant contribution in leading
Unilabs through an exceptional period of growth and building a
strong team over the last four years. His leadership has ensured
Unilabs is in a solid position to continue building upon the
position it has created," said Paul Hökfelt.
"I wish continued success to the Unilabs team, and I would like
to thank my colleagues, partners and customers for these four years
of intensive collaboration," said Jean-Paul Rigaudeau
Contact information:
Paul Hökfelt, Chairman of the Board of Unilabs
Phone: +41 22 7022 001
e-mail: paul.hokfelt@unilabs.com
Investor relations: investor.relations@unilabs.com
About Unilabs:
We are one of Europe's leading suppliers of clinical laboratory
testing and medical diagnostic imaging services to private and
public healthcare providers, local governments, insurance
companies, pharmaceutical companies and the general public. We
operate laboratory and medical diagnostic imaging facilities in 11
countries: Denmark, Finland, France, Italy, Norway, Portugal,
Russia, Spain, Sweden, Switzerland and the United Kingdom. Our
network of facilities provides us with one of the broadest
geographic footprints of any clinical laboratory and medical
diagnostic services provider in Europe. For more information please
visit www.unilabs.com.
About Nordic Capital Private Equity Funds
Since the start in 1989, Nordic Capital Private Equity Funds
have invested in large and medium sized companies, primarily in
Northern Europe. Through committed ownership and by targeting
strategic development and operational improvements, Nordic Capital
creates value in its investments. The funds invest in companies in
Northern Europe and in selected investment opportunities
internationally. They are based in Jersey, Channel Islands, and are
advised by the NC Advisory companies in Sweden, Denmark, Finland,
Norway, Germany and the UK. Additional information about Nordic
Capital is available through its corporate website, www.nordiccapital.com.
